VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Results 1 - 20 of 80 : 1 2 3 4 Next »

Recs

0
Member Avatar s2dbaker (79.14) Submitted: 10/16/2013 11:04:44 PM : Outperform Start Price: $9.66 VVUS Score: -86.33

A pill that help prevent type II diabetes and promotes weight loss. This is a winner.

Recs

0
Member Avatar manirg (73.30) Submitted: 6/14/2013 12:48:32 PM : Outperform Start Price: $14.24 VVUS Score: -103.29

obesity drug will catch on

Recs

0
Member Avatar LIFESAVA1 (< 20) Submitted: 4/19/2013 5:31:47 PM : Outperform Start Price: $11.88 VVUS Score: -105.09

VVUS HAS A GREAT WEIGHT LOSS PRODUCT

Recs

0
Member Avatar TheStockDoctor (< 20) Submitted: 3/3/2013 9:37:23 PM : Underperform Start Price: $10.24 VVUS Score: +104.11

Qsymia was a total flop at initial release, and that is without any competition. As soon as Belviq hits the shelves, Qsymia sales will drop substantially.

Recs

0
Member Avatar SmartEquity (40.43) Submitted: 1/21/2013 9:09:52 AM : Outperform Start Price: $13.34 VVUS Score: -114.87

I believe the scrips will pick up as distribution is improved. The obesity patients will choose a riskier Qsymia over a safer less effective Belviq.

Recs

0
Member Avatar clymerjones (50.62) Submitted: 10/17/2012 11:09:13 AM : Outperform Start Price: $22.25 VVUS Score: -127.13

Strong product/development initiatives will out class the S&P

Recs

0
Member Avatar greatspeculator (38.08) Submitted: 10/3/2012 2:00:40 AM : Outperform Start Price: $18.51 VVUS Score: -125.21

Good fundamentals. Speculation.

Recs

0
Member Avatar dausama (86.66) Submitted: 9/23/2012 9:54:13 AM : Underperform Start Price: $20.62 VVUS Score: +126.81

no EU approval

Recs

0
Member Avatar donodonuts (64.04) Submitted: 8/9/2012 7:16:43 AM : Outperform Start Price: $21.77 VVUS Score: -132.62

Sold it at like 8, oops. But their stuff hasn't hit the market yet, I'd like to think it will go up more when they have actual sales.

Recs

0
Member Avatar rick3000 (< 20) Submitted: 7/17/2012 5:16:39 PM : Underperform Start Price: $30.33 VVUS Score: +141.59

Inflated by ARNA approval, will crash to actual value if rejected or with restrictive label. Management has a black eye from handling of FDA announcement.

Recs

0
Member Avatar ravens9111 (55.25) Submitted: 7/16/2012 11:26:58 AM : Underperform Start Price: $27.97 VVUS Score: +141.10

Betting against this stock's FDA decision tomorrow. Price is most likely already priced in for approval. I expect a sell the news event even if approval is granted. However, if rejected, this stock will go to low teens to high single digits.

Recs

0
Member Avatar HIGHG33K (92.53) Submitted: 7/13/2012 8:39:49 PM : Outperform Start Price: $27.55 VVUS Score: -141.15

FDA approval is inevitable.

Recs

0
Member Avatar natemwilson (42.49) Submitted: 6/28/2012 12:08:47 PM : Underperform Start Price: $28.54 VVUS Score: +145.71

Too many adverse side effects to be approved.

Recs

0
Member Avatar nobleartjim (< 20) Submitted: 6/23/2012 9:48:19 AM : Outperform Start Price: $26.34 VVUS Score: -144.53

Recent developing products now undergoing FDA tests appear favorable

Recs

0
Member Avatar BACnumber1 (< 20) Submitted: 6/12/2012 12:13:40 PM : Outperform Start Price: $24.75 VVUS Score: -143.59

Fine stock, but I'm way bigger on ARNA

Recs

0
Member Avatar GoodTrader1 (< 20) Submitted: 6/6/2012 4:38:42 PM : Outperform Start Price: $24.32 VVUS Score: -141.80

high relative strenght

Recs

0
Member Avatar Wanker01 (53.04) Submitted: 5/1/2012 1:07:03 PM : Outperform Start Price: $24.59 VVUS Score: -133.15

Old people want to do it to

Recs

0
Member Avatar donscaccia (< 20) Submitted: 4/26/2012 10:47:24 AM : Outperform Start Price: $24.37 VVUS Score: -135.30

lets go vvus

Recs

0
Member Avatar JacquesHRoy (< 20) Submitted: 4/18/2012 8:32:42 PM : Outperform Start Price: $22.41 VVUS Score: -134.83

Anti-obesity medication is a big MUST in North-America.

Recs

0
Member Avatar henrytsai (27.54) Submitted: 3/31/2012 12:09:34 AM : Outperform Start Price: $23.00 VVUS Score: -133.07

Will obtain FDA approval thus driving price higher.

Results 1 - 20 of 80 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement